FDA & NIH News / Other than Malignancy (2012.07.31)

2012. . 31
FDA & NIH News / Other than Malignancy

◆FDA approves Linzess to treat certain cases of irritable bowel syndrome and constipation
FDA NEWS RELEASE Aug. 30, 2012
The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.

◆Aspirin-clopidogrel no better than aspirin alone for patients with lacunar stroke
NIH Nwes August 29, 2012
NIH study also shows that overall stroke risk is down from 10 years ago
Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of gastrointestinal bleeding, according to results of a trial funded by the National Institutes of Health. Lacunar strokes occur due to chronic high blood pressure and typically produce small lesions deep within the brain.